_gigi-d39agostino-noise-maker-theme-preview-1.jpg "Gigi D'Agostino - Noise Maker Theme from theme maker Video Screenshot Preview 1")
Gallery_gigi-d39agostino-noise-maker-theme-preview-3.jpg "Gigi D'Agostino - Noise Maker Theme from theme maker Video Screenshot Preview 3")
Gallery_gigi-d39agostino-noise-maker-theme-preview-hqdefault.jpg "Gigi D'Agostino - Noise Maker Theme from theme maker Video Screenshot Preview hqdefault")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Jump To Video Parts
⏲ Duration: 8 minutes 45 seconds
👁 View: 124.4K times
Play Audio:👁 View: 124.4K times
Description:
ProgressiveTrancer
ProgressiveTrancer
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_uvalde-families-sue-meta-and-call-of-duty-maker-on-second-anniversary-of-school-attack.webp "Uvalde families sue Meta and Call of Duty maker on second anniversary of school attack<br/><br/>Families in Uvalde took more legal action on May 24, 2024 on the second anniversary of the Robb Elementary School attack, suing Meta Platforms, which owns Instagram, and the maker of the video game Call of Duty over claims the companies bear responsibility for products used by the teenage gunman. They also filed another lawsuit against Daniel Defense, which manufactured the AR-style rifle used in the May 24, 2022 shooting where 19 students and two teachers were killed. It added to mounting lawsuits over the attack and came as the small Texas city gathered to mourn the anniversary of one of the deadliest school shootings in U.S. history.<br/><br/>Photos by AP<br/><br/>Subscribe to The Manila Times Channel - https://tmt.ph/YTSubscribe <br/>Visit our website at https://www.manilatimes.net <br/> <br/>Follow us: <br/>Facebook - https://tmt.ph/facebook <br/>Instagram - https://tmt.ph/instagram <br/>Twitter - https://tmt.ph/twitter <br/>DailyMotion - https://tmt.ph/dailymotion <br/> <br/>Subscribe to our Digital Edition - https://tmt.ph/digital <br/> <br/>Check out our Podcasts: <br/>Spotify - https://tmt.ph/spotify <br/>Apple Podcasts - https://tmt.ph/applepodcasts <br/>Amazon Music - https://tmt.ph/amazonmusic <br/>Deezer: https://tmt.ph/deezer <br/>Tune In: https://tmt.ph/tunein<br/> <br/>#themanilatimes<br/>#worldnews <br/>#schoolattack<br/>#videogame")
_how-to-create-themes-with-themes-design-studio-by-nada-mohsen-huawei-accredited-designer.webp "Huawei Mobile Services")
⏲ 1 minute 1 second 👁 20K
_major-fire-engulfs-danish-pharmaceutical-company-novo-nordisk.webp "A large fire broke out at Novo Nordisk's offices near Copenhagen today, the second blaze to hit the Ozempic-maker in a week, the company posted on social media.")
_stunning-castle-ideas-amazing-super-mario-maker-2-castle-theme-ideas.webp "Arrowstotle")
⏲ 9 minutes 16 seconds 👁 247.3K
_gigi-d39agostino-noise-maker-theme.webp "ProgressiveTrancer")
_growing-number-of-americans-are-trying-weight-loss-drugs.webp "Growing , Number of Americans Are Trying , Weight-Loss Drugs.<br/>According to a recent poll, six percent of adults <br/>in the United States have already tried Ozempic <br/>or other brand name weight loss medications.<br/>According to a recent poll, six percent of adults <br/>in the United States have already tried Ozempic <br/>or other brand name weight loss medications.<br/>'Newsweek' reports that the Gallup poll numbers<br/>suggest that approximately 15.5 million Americans have <br/>used or are using an injectable diabetes medication. .<br/>'Newsweek' reports that the Gallup poll numbers<br/>suggest that approximately 15.5 million Americans have <br/>used or are using an injectable diabetes medication. .<br/>According to the poll, three percent <br/>of those users are specifically <br/>using the drug for weight loss.<br/>The poll found that people between the ages <br/>of 40 and 64 are the most likely to try Ozempic <br/>or competitors, like Wegovy or Saxenda. .<br/>In 2017, the U.S. Food and Drug <br/>Administration (FDA) approved Ozempic <br/>to treat cardiovascular disease and diabetes. .<br/>'Newsweek' reports that while Ozempic has <br/>not been approved for weight-loss purposes, <br/>its competitor Wegovy was approved in 2021. .<br/>'Newsweek' reports that while Ozempic has <br/>not been approved for weight-loss purposes, <br/>its competitor Wegovy was approved in 2021. .<br/>Both drugs rely upon the active ingredient <br/>semaglutide, however, Wegovy contains <br/>a higher amount than Ozempic.<br/>Both drugs rely upon the active ingredient <br/>semaglutide, however, Wegovy contains <br/>a higher amount than Ozempic.<br/>The popularity of the drug has resulted <br/>in various makers reporting shortages. .<br/>The drug companies didn't <br/>anticipate how popular <br/>these drugs would become, Sue Decotiis, Triple-board-certified medical <br/>weight-loss doctor in New York City, via 'Newsweek'.<br/>Since they are being used <br/>for many issues, like diabetes, <br/>heart failure, obesity, <br/>this exacerbates the <br/>shortages significantly, Sue Decotiis, Triple-board-certified medical <br/>weight-loss doctor in New York City, via 'Newsweek'")
_uvalde-families-sue-meta-and-call-of-duty-maker-on-second-anniversary-of-school-attack.jpg)
_how-to-create-themes-with-themes-design-studio-by-nada-mohsen-huawei-accredited-designer.jpg)
_major-fire-engulfs-danish-pharmaceutical-company-novo-nordisk.jpg)
_stunning-castle-ideas-amazing-super-mario-maker-2-castle-theme-ideas.jpg)
_gigi-d39agostino-noise-maker-theme.jpg)
_growing-number-of-americans-are-trying-weight-loss-drugs.jpg)
![[+]](/images/menu.gif){kind=small}